By accessing and using IXAGEN’s services, you agree to comply with these Terms and Conditions. If you do not agree to these Terms, you may not use our services.

IXAGEN reserves the right to modify these Terms and Conditions at any time. Any changes will be effective immediately upon posting, and continued use of our services constitutes your acceptance of the modified terms.

In these Terms and Conditions, the following terms have specific meanings: 'IXAGEN' refers to our company; 'User' or 'You' refers to anyone accessing our services; 'Services' means the products and solutions provided by IXAGEN.

IXAGEN is committed to protecting user data and ensuring privacy across all jurisdictions where we operate. We comply with relevant regulations, including but not limited to GDPR, CCPA, APPI, PDPA, Australian Privacy Principles, and Swiss Data Protection Act.

For users located in the European Union, IXAGEN adheres to the GDPR, ensuring the lawful, transparent, and secure handling of personal data. Users have rights concerning data access, rectification, erasure, and restriction of processing.

For California residents, IXAGEN complies with the CCPA, which provides users with rights related to data collection, access, deletion, and opting out of data sale. Users can contact us to exercise their rights.

For users located in Japan, IXAGEN complies with APPI standards, protecting users’ personal data and maintaining transparent data practices, including consent for data collection and transfer.

For users in Singapore, IXAGEN follows the PDPA, which outlines personal data protection, including data collection, processing, and user consent for personal data use.

IXAGEN complies with the Australian Privacy Principles, ensuring the protection and secure handling of personal data for users in Australia and providing transparency in our data practices.

For users in the United Kingdom, IXAGEN adheres to both the UK Data Protection Act and GDPR, ensuring user rights to access, rectify, and restrict the processing of personal data.

For users in Switzerland, IXAGEN complies with the Swiss Data Protection Act, which provides protections regarding data collection, processing, and transfer of personal data.

To access IXAGEN’s services, users must create an account by providing accurate and up-to-date information. Users are responsible for maintaining the confidentiality of their account credentials and for all activities that occur under their account.

Users must safeguard their account credentials and notify IXAGEN immediately of any unauthorized access or security breaches. IXAGEN is not liable for any loss or damage arising from a user's failure to comply with these security obligations.

By using IXAGEN’s services, users agree to comply with all applicable laws and regulations. Users are prohibited from engaging in activities that could harm or impair the operation of the services, including but not limited to fraudulent activities, misuse of resources, and unauthorized access attempts.

All content, features, and functionalities within IXAGEN’s services, including text, graphics, logos, and software, are the exclusive property of IXAGEN or its licensors. Unauthorized use, reproduction, or distribution of any content is strictly prohibited.

Users retain ownership of any content they create and upload to IXAGEN’s platform. By submitting content, users grant IXAGEN a worldwide, non-exclusive, royalty-free license to use, display, and distribute the content within the scope of the services.

If you believe your intellectual property rights have been infringed, please contact us at [https://ixagen.com/information] to report the issue. IXAGEN respects intellectual property rights and will take appropriate action to address any valid claims.

IXAGEN collects data necessary for the provision of services, including personal information as outlined in our Privacy Policy. This data is collected only with user consent or as permitted by law.

Data collected by IXAGEN is used solely to enhance, provide, and secure our services. We do not sell personal data to third parties, and data usage complies with relevant regulations and user consent.

IXAGEN implements industry-standard security protocols to protect user data from unauthorized access, alteration, disclosure, or destruction. Our security measures include data encryption, secure access controls, and regular audits.

IXAGEN engages third-party service providers for specific services and ensures that all third parties comply with data protection regulations through Data Processing Agreements. These agreements ensure secure data handling and restrict data use to approved purposes.

IXAGEN’s services are offered on a subscription or usage-based pricing model, as specified on our website. Pricing details are subject to change, and users will be notified in advance of any changes that may affect their subscription.

Payments are due on the specified billing date for each subscription period. Users agree to provide valid payment information and authorize IXAGEN to charge the applicable fees. Late or missed payments may result in service suspension.

Refunds are available only as specified in our refund policy. Users seeking a refund must contact us via [https://ixagen.com/information] within the eligible timeframe. Refund requests will be evaluated based on the circumstances outlined in our policy.

Users may cancel their subscription by following the cancellation process in their account settings. Cancellations will take effect at the end of the current billing cycle, and users retain access to services until the end of that period.

To the fullest extent permitted by law, IXAGEN shall not be liable for any direct, indirect, incidental, special, or consequential damages arising out of or in connection with the use of our services, including but not limited to loss of data, revenue, or profits. IXAGEN’s total liability for any claims related to the service is limited to the amount paid by the user for the specific service giving rise to the claim.

Users agree to indemnify, defend, and hold harmless IXAGEN, its affiliates, officers, directors, employees, and agents from any claims, liabilities, damages, losses, and expenses, including reasonable attorney fees, arising out of or in any way connected to their use of the services, violation of these Terms, or infringement of any rights of another.

These Terms and Conditions are governed by and construed in accordance with the laws of Singapore, without regard to its conflict of law principles. Users agree to submit to the exclusive jurisdiction of the courts in Singapore for any disputes arising out of or related to these Terms.

In the event of a dispute, users agree to first attempt resolution through mediation. If mediation fails, disputes shall be resolved by binding arbitration, conducted in Singapore, in accordance with the rules of the Singapore International Arbitration Centre (SIAC). The arbitrator’s decision shall be final and binding on both parties.

Users may have additional rights or obligations under local laws applicable to their jurisdiction. IXAGEN will comply with all applicable laws and regulations, and users should consult local laws for specific requirements regarding dispute resolution in their region.

For users located in the EU and UK, IXAGEN complies with the General Data Protection Regulation (GDPR) and the UK Data Protection Act. Users have the right to access, rectify, and erase their personal data and may contact us at [https://ixagen.com/information] to exercise these rights.

For users in California, IXAGEN complies with the California Consumer Privacy Act (CCPA). California residents have rights regarding their data, including the right to access, delete, and opt-out of the sale of personal information. Users may contact us at [https://ixagen.com/information] to exercise these rights.

For users in Japan, IXAGEN complies with Japan’s Act on the Protection of Personal Information (APPI), which provides rights concerning data access, rectification, and consent for data transfer. Users may contact us at [https://ixagen.com/information] to request information or exercise their rights.

For users in Singapore, IXAGEN adheres to the Personal Data Protection Act (PDPA). Users have rights concerning the collection, use, and disclosure of their personal data. To exercise these rights, please contact us at [https://ixagen.com/information].

For users in Australia, IXAGEN complies with the Australian Privacy Principles (APPs) and provides transparency on data handling and user rights. Users may contact us at [https://ixagen.com/information] for inquiries about their data.

For users in Switzerland, IXAGEN complies with the Swiss Data Protection Act, providing users with rights to access, correct, and control the use of their personal data. Users may contact us at [https://ixagen.com/information] for data-related inquiries.

IXAGEN shall not be held liable for any delay or failure to perform obligations under these Terms due to events beyond our reasonable control, including natural disasters, acts of war, cyber attacks, government actions, or other force majeure events.

If any provision of these Terms is found to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions shall remain in full force and effect.

These Terms and Conditions, along with our Privacy Policy and any additional agreements referenced herein, constitute the entire agreement between the user and IXAGEN, superseding any prior agreements or understandings regarding the use of our services.

Users of IXAGEN’s services have the right to access, modify, and delete their personal data as outlined in our Privacy Policy. Users can also contact us at [https://ixagen.com/information] to exercise additional rights specific to their jurisdiction, including the right to data portability and the right to restrict processing.

Users agree to use IXAGEN’s services in compliance with applicable laws and these Terms. Users are responsible for ensuring the accuracy of information provided to IXAGEN and must not engage in any activity that could disrupt or harm our services, including but not limited to fraudulent actions, unauthorized access, and interference with other users’ access.

IXAGEN will communicate important updates, changes to these Terms, and other relevant information via email or through in-app notifications. By using our services, users agree to receive such communications in the specified formats.

IXAGEN reserves the right to amend these Terms and Conditions. Users will be notified of significant changes via email or through our platform. Continued use of the services after any amendments constitutes acceptance of the updated Terms.

By accessing and using IXAGEN’s services, users acknowledge that they have read, understood, and agree to be bound by these Terms and Conditions. If users have any questions regarding these Terms, they are encouraged to contact us at [https://ixagen.com/information].